Community-acquired Legionnaires' disease at a medical center in northern Taiwan
- PMID: 28964650
- DOI: 10.1016/j.jmii.2017.08.018
Community-acquired Legionnaires' disease at a medical center in northern Taiwan
Abstract
Background/purpose: Legionella pneumophila had been recognized as an important pathogen for community-acquired pneumonia. We aimed to investigate clinical features and outcomes of patients with Legionnaires' disease at a tertiary medical center in northern Taiwan.
Methods: From June 2012 to February 2017, a retrospective review of adult community-acquired. Legionnaires' disease at a medical center was conducted. All Legionella infections were confirmed by positive urinary Legionella antigen assay, sera indirect immunofluorescence assay, or sputum culture for Legionella. Literature review of Legionnaires' disease from Medline and PubMED websites was performed.
Results: A total of 32 cases of Legionnaires' disease were identified. Their mean age was 64.3 years, with male predominance (27 cases, 84.3%). The underlying diseases were varied and most were attributed to chronic disorders, such as diabetes mellitus (31%) and cigarette smoking (40.6%). The most common symptoms were cough (68%) and fever (59.3%). More than half of patients (18, 56.2%) with Legionnaires' disease could initially present with extrapulmonary manifestations. Sixteen (50%) patients had delay in initiation of appropriate antibiotic therapy. Patients without adequately initiation of appropriate antibiotic therapy had higher proportion (11 of 16, 68.7%) of intensive care unit admission than patients with adequate initiation (5 of 16, 31.2%). Our results inferred that a delay in treatment might result in worsening of disease severity and the need for more intensive management. Overall mortality rate was 21.8%. Development of vasopressor requirement is an independent risk factor associated with mortality.
Conclusion: Legionnaires' disease in Taiwan frequently present with extrapulmonary manifestations. Patients with hemodynamic instability that need vasopressor therapy associated with mortality.
Keywords: Community-acquired pneumonia; Fluoroquinolone; Legionnaires' disease; Macrolide.
Copyright © 2017. Published by Elsevier B.V.
Similar articles
-
Legionella pneumonia in the Niagara Region, Ontario, Canada: a case series.J Med Case Rep. 2016 Dec 1;10(1):336. doi: 10.1186/s13256-016-1105-2. J Med Case Rep. 2016. PMID: 27906087 Free PMC article.
-
Legionnaires' disease at a medical center in southern Taiwan.J Microbiol Immunol Infect. 2018 Jun;51(3):352-358. doi: 10.1016/j.jmii.2016.08.006. Epub 2016 Dec 18. J Microbiol Immunol Infect. 2018. PMID: 28094205
-
Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.Medicine (Baltimore). 2013 Jan;92(1):51-60. doi: 10.1097/MD.0b013e31827f6104. Medicine (Baltimore). 2013. PMID: 23266795 Free PMC article.
-
An update on Legionella.Curr Opin Infect Dis. 2010 Apr;23(2):152-7. doi: 10.1097/QCO.0b013e328336835b. Curr Opin Infect Dis. 2010. PMID: 20051846
-
[Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].Enferm Infecc Microbiol Clin. 2003 Oct;21(8):394-400. Enferm Infecc Microbiol Clin. 2003. PMID: 14525703 Review. Spanish.
Cited by
-
Incidence and risk factors associated with progression to severe pneumonia among adults with non-severe Legionella pneumonia.Acute Crit Care. 2022 Nov;37(4):543-549. doi: 10.4266/acc.2022.00521. Epub 2022 Oct 21. Acute Crit Care. 2022. PMID: 36330734 Free PMC article.
-
Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.J Microbiol Immunol Infect. 2019 Dec;52(6):920-928. doi: 10.1016/j.jmii.2019.10.009. Epub 2019 Nov 23. J Microbiol Immunol Infect. 2019. PMID: 31806539 Free PMC article.
-
Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.Clin Infect Dis. 2021 Jun 1;72(11):1979-1989. doi: 10.1093/cid/ciaa441. Clin Infect Dis. 2021. PMID: 32296816 Free PMC article.
-
Severe Legionnaires' disease.Ann Intensive Care. 2024 Apr 2;14(1):51. doi: 10.1186/s13613-024-01252-y. Ann Intensive Care. 2024. PMID: 38565811 Free PMC article. Review.
-
A retrospective observational cohort study of oral azithromycin treatment for Legionnaires' disease.J Antimicrob Chemother. 2025 May 2;80(5):1354-1361. doi: 10.1093/jac/dkaf081. J Antimicrob Chemother. 2025. PMID: 40116673 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical